Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 967 across all filing types
Latest filing 2026-05-29 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于召开2026年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a notice of a 2026 extraordinary general shareholders meeting, detailing meeting time, venue, agenda items, registration and proxy voting procedures, and attached proxy and voting forms. It is not a report publication announcement or financial report but rather the solicitation of proxies and informational materials to shareholders for voting. This aligns with the Proxy Solicitation & Information Statement category.
2026-05-29 Chinese
关于补选非独立董事暨聘任副总经理、财务总监的公告
Board/Management Information Classification · 95% confidence The document is a corporate announcement in Chinese titled “补选非独立董事暨聘任副总经理、财务总监的公告,” detailing the by-election of a non-independent director and the appointment of a deputy general manager and CFO. It describes board resolutions and management appointments. This fits the Board/Management Information category.
2026-05-29 Chinese
关于董事、副总经理、董事会秘书兼财务负责人辞职暨聘任董事会秘书的公告
Board/Management Information Classification · 85% confidence The document is an announcement by the company regarding the resignation of a sitting director, vice general manager, board secretary and financial officer, and the appointment of a new board secretary. This clearly describes changes in senior management and board positions, fitting the “Board/Management Information” category.
2026-05-29 Chinese
关于持股 5%以上股东提前终止减持计划暨减持股份结果的公告
Major Shareholding Notification Classification · 95% confidence The text is a Chinese stock exchange announcement detailing the early termination of a share reduction plan and the resulting shareholding percentages of a 5%+ shareholder. This is a notification of changes in significant share ownership levels by a major shareholder, not a company share buyback or an insider trade by executives. This aligns with the “Major Shareholding Notification” category.
2026-05-27 Chinese
关于公司医疗器械产品完成延续注册的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a listed company regarding completion of regulatory renewal registration for a medical device product issued by the national drug regulatory authority. It contains no financial statements, no voting results, no management changes, no share transactions, and is not a formal financial or governance report. It is a general regulatory compliance announcement, falling under the fallback category for miscellaneous regulatory filings.
2026-05-22 Chinese
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 92% confidence The document is an official announcement detailing the implementation of the 2025 annual equity distribution (cash dividend per 10 shares), including record date, ex-dividend date, dividend amount, payment arrangements, and related parameters. It does not present full financial statements or operational results but specifically focuses on dividend distribution details, fitting the definition of a Notice of Dividend Amount (DIV).
2026-05-20 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.